Logo

American Heart Association

  16
  0


Final ID: MP30

Trends in Stroke-Related Mortality Among U.S. Patients with Hyperlipidemia, 1999–2020: A CDC WONDER Analysis

Abstract Body (Do not enter title and authors here): Background: Stroke-related mortality has been rising in the United States. Understanding its association with modifiable risk factors, such as hyperlipidemia (HLD), is critical for prevention. This study analyzes trends and disparities in stroke-related mortality among patients with HLD in the United States from 1999 to 2020.
Methods: Using data from CDC WONDER (Center for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research), we calculated annual stroke-related age-adjusted mortality rates (AAMR) per 100,000 in patients with HLD from 1999 to 2020 and stratified them by sex and race. Stroke-related deaths were defined as those with stroke (ICD-10 I60–I69) as the underlying cause and hyperlipidemia listed as a contributing condition. JoinPoint regression analysis was used to assess trends and estimate annual percent changes (APC).
Results: From 1999 to 2020, there were 58,661 stroke-related deaths in patients with HLD, with an overall AAMR of 0.8 per 100,000. AAMR increased throughout the period, rising rapidly from 0.3 in 1999 to 0.7 in 2006 (APC +13.7%, p<0.001), followed by a slower increase to 1.2 in 2020 (APC +2.8%, p=0.002). Female and male patients exhibited similar trends. AAMR was 0.3 for both sexes in 1999 and rose to 1.1 in females and 1.2 in males by 2020. Initially, Black or African American patients and White patients had similar AAMRs; however, AAMR increased more rapidly in Black patients compared to White patients. Among Black patients, AAMR rose from 0.2 in 1999 to 0.7 in 2004 (APC +24.6%, p<0.001), then further increased to 1.4 in 2020 (APC +4.2%, p=0.001). In White patients, AAMR rose from 0.2 in 1999 to 0.7 in 2006 (APC +13.7%, p<0.001) and to 1.1 in 2020 (APC +2.6%, p<0.001).
Conclusion: Stroke-related mortality in patients with HLD increased steadily from 1999 to 2020. Trends were similar between male and female patients. However, AAMR rose more rapidly among Black patients than White patients, underscoring growing disparities.
  • Al-nusair, Mohammed  ( MedStar Washington Hospital Center , Washington , District of Columbia , United States )
  • Haider, Waqas  ( MedStar Heart Vascular Institute , Washington , District of Columbia , United States )
  • Author Disclosures:
    Mohammed Al-Nusair: DO NOT have relevant financial relationships | Waqas Haider: DO have relevant financial relationships ; Advisor:Kiniksa Pharmaceuticals:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Stroke, Comorbidities, and Care Gaps: Trends, Risks, and Treatments

Saturday, 11/08/2025 , 03:15PM - 04:05PM

Moderated Digital Poster Session

More abstracts on this topic:
Access to Lipid-Lowering Therapies is Limited by Payer Coverage Restrictions and High Out-of-Pocket Costs on Medicare Prescription Drug Plans

Young Grant, Bansal Kannu, Riello Ralph, Faridi Kamil, Clark Katherine, Desai Nihar

Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, for Lowering LDL Cholesterol in Adults with or At-Risk for ASCVD: The Phase 3 CORALreef Lipids Trial

Navar Ann Marie, Mendizabal Geraldine, Nuez Llota Julio, Zhu Pengfei, Zhuo Min, Ballantyne Christie, Mikhailova Elina, Catapano Alberico, Banka Puja, Blom Dirk, Cadena Alberto, Kourpanidis Susan, Lepor Norman, Tsukamoto Kazuhisa

You have to be authorized to contact abstract author. Please, Login
Not Available